Today's Information

Provided by: CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
SEQ_NO 1 Date of announcement 2022/04/20 Time of announcement 16:22:52
Subject
 Update private placement area-It should be
reported within two days from the date of the resolution
of board of directors(private placement conversion )
Date of events 2022/04/20 To which item it meets paragraph 51
Statement
1.Date of occurrence of the event:2022/04/20
2.Company name:China Chemical Pharmaceutical Co., Ltd.
3.Relationship with the Company (please enter "the company itself"
or "subsidiaries"):the company itself
4.Reciprocal shareholding percentage:N/A
5.Cause of occurrence:Amendment of the issuance conditions for private
placement of domestic convertible corporate bonds including secured or
unsecured convertible corporate bonds
6.Information items/ statements to be corrected:Private placement
conditions and the rationality of private placement conditions
7.Amounts/ contents/ number of page to be corrected:
(1) Private placement conditions:
The issue price of privately placed convertible corporate bonds shall
not be lower than 80% of the theoretical price. The theoretical price
will be determined based on a pricing model that covers and takes into
account the various rights contained in the issuance conditions.
(2) The rationality of private placement conditions:
The private placement price including the private placement convertible
corporate bond conversion price will be determined in accordance with
the laws and regulations of the competent authority, with reference to
the above reference price or theoretical price, and considering the
three-year transfer restriction of private placement securities under
the Securities and Exchange Act, so the price is determined .
it should be reasonable.
8.Amounts/ contents/ number of page after correction:
(1) Private placement conditions:
1. Types of private equity shares: domestic convertible corporate bonds
including secured or unsecured convertible corporate bonds.
2. Face value per bond: NT$100,000 or its multiples.
3. Issue period: not more than seven years from the issue date.
4. Coupon rate: tentatively set at 0% per annum.
5. The issue price of privately placed convertible corporate bonds shall
not be lower than 80% of the theoretical price. The theoretical price
will be determined based on a pricing model that covers and takes into
account the various rights contained in the issuance conditions.
The conversion price is calculated on the basis of the simple arithmetic
average of the closing price of the common stock one, three or five
business days before the pricing date, minus the ex-rights and dividends
of the free allotment, and adding back the share price after capital
reduction and anti-ex-rights, or 30 business days before the pricing date.
The simple arithmetic average of the daily closing price of ordinary shares
deducts the ex-rights and dividends of the free allotment, and adds back
the share price after capital reduction and anti-ex-rights.
(2) The rationality of private placement conditions:
1. The issue price of privately placed convertible corporate bonds shall not
be lower than 80% of the theoretical price. The theoretical price will be
determined based on a pricing model that covers and takes into account the
various rights contained in the issuance conditions. The conversion price is
calculated on the basis of the simple arithmetic average of the closing price
of the common stock one, three or five business days before the pricing date,
minus the ex-rights and dividends of the free allotment, and adding back the
share price after capital reduction and anti-ex-rights, or 30 business days
before the pricing date. The simple arithmetic average of the daily closing
price of ordinary shares deducts the ex-rights and dividends of the free
allotment, and adds back the share price after capital reduction and
anti-ex-rights.
2. The private placement price including the private placement convertible
corporate bond conversion price)will be determined in accordance with the
laws and regulations of the competent authority, with reference to the above
reference price or theoretical price, and considering the three-year transfer
restriction of private placement securities under the Securities and Exchange
Act, so the price is determined. should be reasonable.
9.Countermeasures:
Upload to Public Information Observatory after update
10.Any other matters that need to be specified:none

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

CCPC – China Chemical and Pharmaceutical Co. Ltd. published this content on 20 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2022 08:34:04 UTC.